Search clinical trials for: DP-R213

Total 436 results

Alvogen Korea

Withdrawn

Clinical Trial to Evaluate the Efficacy and Safety of DP-R212

Hypertension | Hypercholesterolemia
D-Pharm Ltd.

Withdrawn

DP-VPA for Migraine Prophylaxis, a Pilot Efficacy Study

Migraine

Israel
Neurolief Ltd.

Active, not recruiting

The MOOD Study - External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for the Treatment of Major Depressive Disorder (MDD) (MDD)

MDD

United States, Israel
Galderma R&D

Completed

Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines

Glabellar Frown Lines | Canthal Lines

United States
D-Pharm Ltd.

Completed

Effects Of DP-b99 On Neurological Function In Subjects With Acute Ischemic Hemispheric Stroke

Stroke | Cerebrovascular Disorders | Brain Ischemia

Israel, Germany
ReNeuron Limited

Completed

Pilot Investigation of Stem Cells in Stroke Phase II Efficacy (PISCES-II)

Cerebral Infarction | Hemiparesis | Ischaemic Stroke | Arm Paralysis

United Kingdom
AgonOx, Inc.
Providence St Joseph Health; Phio Pharmaceuticals Corp.

Recruiting

Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors (ACT)

Melanoma | Gynecologic Cancer | Colorectal Cancer | Lung Cancer | HNSCC | Urogenital Cancer

United States
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

Arterial dP/dt Dependency on Loading Conditions (REABILITY)

Intraoperative Hemodyamic Monitoring

Italy
Factor Therapeutics Ltd.
Parexel; ARANZ Medical; Almac Clinical Services LLC

Unknown

Study of VF001-DP in Patients With Chronic Venous Leg Ulcers

Pathologic Processes | Cardiovascular Diseases | Vascular Diseases | Skin Diseases | Ulcer | Leg Ulcer | Skin Ulcer | Varicose Ulcer

United States
University Hospital, Grenoble

Unknown

Electronic Pharmaceutical Record Used for Medication Reconciliation by a Pharmacist Associated to the Anesthesiologist Consultation (DP-CONCIL)

Electronic Health Records

France
Universidad de Extremadura

Completed

Textbook Outcome in Distal Pancreatectomy (TO-ERPANDIS)

Distal Pancreatectomy
ReNeuron Limited

Completed

Safety Trial Of CTX Cells In Patients With Lower Limb Ischaemia

Peripheral Arterial Disease

United Kingdom
Seoul National University Hospital

Completed

Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents (Grand-DES)

Coronary Artery Disease

Korea, Republic of
University Hospital, Clermont-Ferrand
Pôle Santé République; Service de Néphrologie et Hémodialyse; Jacques Lacarin...

Unknown

Measurement of the Energy Metabolism of Peritoneal Dialysis Patients (CALIMERO 2)

Renal Failure

France
Fundación para la Investigación del Hospital Clínico...

Unknown

OLA to Lowest DP in Cardiac Surgery

Lung Collapse

Spain
Laboratorios Leti, S.L.

Completed

Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma

Asthma | Rhinitis | Rhinoconjunctivitis

Spain
Alvogen Korea

Completed

DP-R213 Phase 1 Pharmacokinetics Study

Healthy
Breath of Life International Pharma Ltd

Withdrawn

BOL-DP-o-05 as an Add-On Treatment of Subjects With Newly Diagnosed Type 1 Diabetes Mellitus

Type1 Diabetes Mellitus
Breath of Life International Pharma Ltd

Terminated

Phase 2a Study Examining the Safety and Efficacy of BOL-DP-o-04 for Treating Diabetic Neuropathy

Diabetic Neuropathy

Israel
Breath of Life International Pharma Ltd

Withdrawn

A Study to Evaluate the Safety and Efficacy of BOL-DP-o-08 in Patients With Endometriosis Syndrome.

Endometriosis
Cyprus University of Technology

Unknown

Management of my Bipolarity Intervention in Bipolar Disorder Patients (MoB)

Bipolar Disorder | Depression, Bipolar | Affective Psychosis, Bipolar | Manic-Depressive Psychosis

Cyprus
Medtronic Bakken Research Center
Medtronic

Completed

Cardiac Resynchronization Therapy (CRT)-Narrow-dp/Dt-Study (CRT-Narrow)

Heart Failure

Germany
Alvogen Korea

Completed

DP-R213 Pharmacokinetics Study

Healthy
Daiichi Sankyo, Inc.

Active, not recruiting

U3-1402 in Metastatic or Unresectable Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer (NSCLC)

United States, Spain, Korea, Republic of, Netherlands, Taiwan, Japan
Philipps University Marburg Medical Center

Completed

Components of Placebo Effects in Sadness (COPES)

Dysphoric Mood

Germany
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

Discomfort Perceived by a Cohort of Patients Treated With Aligners and Attachments Placed According to Two Different Protocols (ATTACH-1)

Malocclusion

Italy
Suzhou Abogen Biosciences Co., Ltd.

Active, not recruiting

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19 Omicron) mRNA Vaccine (Phase 1)

COVID-19

United Arab Emirates
Galderma R&D

Active, not recruiting

Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines

Glabellar Frown Lines

United States
Alvogen Korea

Completed

Efficacy/Safety of DP-R207 Tablet Versus CRESTOR Tablet in Patients With Primary Hypercholesterolemia (ROSE)

Primary Hypercholesterolemia

Korea, Republic of
Breath of Life International Pharma Ltd

Completed

BOL-DP-o-04 in Patients With Low Back Pain and Sciatica

Low Back Pain | Sciatica

Israel
Formation Biologics

Unknown

Safety and Tolerability Study of AVID200 in Pts With Diffuse Cutaneous Systemic Sclerosis

Scleroderma, Diffuse

United States
Qurgen Inc.

Recruiting

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Breast Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Solid Tumor

United States
Grant Dorsey, M.D, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID); Karolinska Institutet and other collaborators

Active, not recruiting

Modifying Immunity in Children With DihydROartemisinin-Piperaquine (MIC-DroP) (MIC-DroP)

Malaria

Uganda
Janssen Vaccines & Prevention B.V.
National Institute of Allergy and Infectious Diseases (NIAID); Beth Israel... and other collaborators

Completed

Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention

Healthy

United States, South Africa, Thailand, Uganda, Rwanda
Dong-A ST Co., Ltd.

Completed

Phamacokinetics and Safety Profiles of DA-5213 10mg in Healthy Subjects

Healthy

Korea, Republic of
GenSight Biologics

Recruiting

Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa (PIONEER)

Non-syndromic Retinitis Pigmentosa

United States, France, United Kingdom
Suzhou Abogen Biosciences Co., Ltd.

Active, not recruiting

A Study to Evaluate Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19) mRNA Vaccines

COVID-19

Indonesia
D-Pharm Ltd.

Terminated

Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke (MACSI)

Acute Ischemic Stroke

Spain, Korea, Republic of, Israel, United States, France, Canada, Brazil, South Africa, Netherlands, Czech Republic, Austria, Germany, Italy, Hungary, Poland, Portugal, Slovakia, Switzerland
Kenya Medical Research Institute
London School of Hygiene and Tropical Medicine; Centers for Disease Control... and other collaborators

Completed

Efficacy of Intermittent Screening and Treatment or Intermittent Preventive Treatment (IPT) With Dihydroartemisinin-Piperaquine, Versus IPT With Sulfadoxine-Pyrimethamine for the Control of Malaria in Pregnancy in Kenya (STOP MiP KENYA)

Pregnancy | Malaria

Kenya
University of Oxford
Mahidol Oxford Tropical Medicine Research Unit

Completed

P.Vivax Treatment Trial (Lao Pv)

Plasmodium Vivax

Lao People's Democratic Republic
Makerere University
Bill and Melinda Gates Foundation

Completed

School Based Malaria Control in Ugandan Schoolchildren (SBMC)

Malaria

Uganda
Xiaoyu Zhu
Nanjing Bioheng Biotech Co., Ltd.

Recruiting

RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBL

Neoplasms | Hematologic Diseases | Hematologic Neoplasms

China
He Huang
Nanjing Bioheng Biotech Co., Ltd.

Recruiting

CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL

Neoplasms | Neoplasms by Site | Hematologic Diseases | Hematologic Neoplasms

China
Instituto Nacional de Ciencias Medicas y Nutricion...

Completed

Effect of Functional Foods on Gut Microbiota in Metabolic Syndrome (MetS)

Metabolic Syndrome

Mexico
University of Oxford

Completed

VAC 072-An Efficacy Study of R21/MM in Different Dose Schedules

Malaria

United Kingdom
Henan Cancer Hospital
Nanjing Bioheng Biotech Co., Ltd.

Recruiting

RD13-02 for Patients With r/r CD7+ T Cell Hematologic Malignancies

Hematologic Malignancies

China
MEI HENG
Nanjing Bioheng Biotech Co., Ltd.

Recruiting

Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological Malignancies

Neoplasms | Neoplasms by Site | Hematologic Diseases | Hematologic Neoplasms

China
Min Xiang

Unknown

RD13-01 for Patients With r/r CD7+ T-ALL/T-LBL

T-lymphoblastic Lymphoma | T Acute Lymphoblastic Leukemia

China
Alvogen Korea

Completed

Safety and Pharmacokinetic Characteristics of DP-R202 in Healthy Male Volunteers

Healthy

Korea, Republic of
Kai Lin Xu，MD
Nanjing Bioheng Biotech Co., Ltd.

Recruiting

Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML)

Neoplasms | Hematologic Diseases | Hematologic Neoplasms

China

Search clinical trials for: DP-R213

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uganda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations